Literature DB >> 12605463

An exploratory instrumental variable analysis of the outcomes of localized breast cancer treatments in a medicare population.

Jack Hadley1, Daniel Polsky, Jeanne S Mandelblatt, Jean M Mitchell, Jane C Weeks, Qin Wang, Yi-Ting Hwang.   

Abstract

This study is motivated by the potential problem of using observational data to draw inferences about treatment outcomes when experimental data are not available. We compare two statistical approaches, ordinary least-squares (OLS) and instrumental variables (IV) regression analysis, to estimate the outcomes (three-year post-treatment survival) of three treatments for early stage breast cancer in elderly women: mastectomy (MST), breast conserving surgery with radiation therapy (BCSRT), and breast conserving surgery only (BCSO). The primary data source was Medicare claims for a national random sample of 2907 women (age 67 or older) with localized breast cancer who were treated between 1992 and 1994. Contrary to randomized clinical trial (RCT) results, analysis with the observational data found highly significant differences in survival among the three treatment alternatives: 79.2% survival for BCSO, 85.3% for MST, and 93.0% for BCSRT. Using OLS to control for the effects of observable characteristics narrowed the estimated survival rate differences, which remained statistically significant. In contrast, the IV analysis estimated survival rate differences that were not significantly different from 0. However, the IV-point estimates of the treatment effects were quantitatively larger than the OLS estimates, unstable, and not significantly different from the OLS results. In addition, both sets of estimates were in the same quantitative range as the RCT results.We conclude that unadjusted observational data on health outcomes of alternative treatments for localized breast cancer should not be used for cost-effectiveness studies. Our comparisons suggest that whether one places greater confidence in the OLS or the IV results depends on at least three factors: (1) the extent of observable health information that can be used as controls in OLS estimation, (2) the outcomes of statistical tests of the validity of the instrumental variable method, and (3) the similarity of the OLS and IV estimates. In this particular analysis, the OLS estimates appear to be preferable because of the instability of the IV estimates. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2003        PMID: 12605463     DOI: 10.1002/hec.710

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  24 in total

1.  There's a reason they call them dummy variables: a note on the use of structural equation techniques in comparative effectiveness research.

Authors:  William H Crown
Journal:  Pharmacoeconomics       Date:  2010       Impact factor: 4.981

Review 2.  Estimating the effect of smoking cessation on weight gain: an instrumental variable approach.

Authors:  Daniel Eisenberg; Brian C Quinn
Journal:  Health Serv Res       Date:  2006-12       Impact factor: 3.402

Review 3.  When and how to use instrumental variables in palliative care research.

Authors:  Joan D Penrod; Nathan E Goldstein; Partha Deb
Journal:  J Palliat Med       Date:  2009-05       Impact factor: 2.947

4.  Effect of evidence-based acute pain management practices on inpatient costs.

Authors:  John M Brooks; Marita G Titler; Gail Ardery; Keela Herr
Journal:  Health Serv Res       Date:  2009-02       Impact factor: 3.402

5.  Estimating Decision-Relevant Comparative Effects Using Instrumental Variables.

Authors:  Anirban Basu
Journal:  Stat Biosci       Date:  2011-09

6.  Validation of disability status, a claims-based measure of functional status for cancer treatment and outcomes studies.

Authors:  Amy J Davidoff; Lisa D Gardner; Ilene H Zuckerman; Franklin Hendrick; Xuehua Ke; Martin J Edelman
Journal:  Med Care       Date:  2014-06       Impact factor: 2.983

7.  Problems with public reporting of cancer quality outcomes data.

Authors:  Paul Goldberg; Rena M Conti
Journal:  J Oncol Pract       Date:  2014-05       Impact factor: 3.840

8.  Rural-Urban Differences in the Effect of Follow-Up Care on Postdischarge Outcomes.

Authors:  Matthew Toth; Mark Holmes; Courtney Van Houtven; Mark Toles; Morris Weinberger; Pam Silberman
Journal:  Health Serv Res       Date:  2016-08-08       Impact factor: 3.402

9.  Comparing the cost effectiveness of risperidone and olanzapine in the treatment of schizophrenia using the net-benefit regression approach.

Authors:  Annemieke De Ridder; Diana De Graeve
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

10.  The selection of an appropriate count data model for modelling health insurance and health care demand: case of Indonesia.

Authors:  Budi Hidayat; Subhash Pokhrel
Journal:  Int J Environ Res Public Health       Date:  2009-12-29       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.